LeonaBio (LONA) Current Leases (2020 - 2026)

LeonaBio (LONA) reported Current Leases of $478000.0 for Q1 2026, up 12.21% year-over-year from $426000.0 in Q1 2025, and up 2.8% quarter-over-quarter from $465000.0 in Q4 2025.

LeonaBio (LONA) Current Leases (2020 - 2026) Analysis & Trends

LeonaBio (LONA) has 7 years of Current Leases data on file, last reported at $478000.0 in Q1 2026.

  • Current Leases for Q1 2026 came in at $478000.0, up 12.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $478000.0 (up 12.21% YoY), and the FY2025 annual result was $465000.0, up 12.32% from the prior year.
  • Current Leases climbed to $478000.0 in Q1 2026 per LONA's latest filing, from $465000.0 in the prior quarter.
  • Over five years, Current Leases peaked at $478000.0 in Q1 2026 and troughed at $297000.0 in Q1 2022.
  • A 5-year average of $382529.4 and a median of $380000.0 in 2024 frame the typical range for Current Leases.
  • The sharpest annual moves came in 2022 and 2025: Current Leases surged 48.5% in 2022, then grew 12.11% in 2025.
  • A 5-year view of Current Leases shows it stood at $326000.0 in 2022, then grew by 12.88% to $368000.0 in 2023, then grew by 12.5% to $414000.0 in 2024, then gained by 12.32% to $465000.0 in 2025, then advanced by 2.8% to $478000.0 in 2026.
  • Business Quant data shows LONA's Current Leases at $478000.0 in Q1 2026, $465000.0 in Q4 2025, and $452000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 83,991.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 7.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 LeonaBio 154.12 Mn 86.44 Mn - 478,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 478,000.00
Dec 31, 2025 465,000.00
Sep 30, 2025 452,000.00
Jun 30, 2025 439,000.00
Mar 31, 2025 426,000.00
Dec 31, 2024 414,000.00
Sep 30, 2024 402,000.00
Jun 30, 2024 391,000.00
Mar 31, 2024 380,000.00
Dec 31, 2023 368,000.00
Sep 30, 2023 358,000.00
Jun 30, 2023 347,000.00
Mar 31, 2023 337,000.00
Dec 31, 2022 326,000.00
Sep 30, 2022 316,000.00
Jun 30, 2022 307,000.00
Mar 31, 2022 297,000.00
Dec 31, 2021 288,000.00
Sep 30, 2021 279,000.00
Jun 30, 2021 263,000.00